Benedetta di Robilant

Benedetta Di Robilant is a highly accomplished professional in the fields of stem cell biology and regenerative medicine, currently serving as Co-Founder and Chief Scientific Officer at Dorian Therapeutics since August 2018. In addition, Benedetta holds the position of Scientific Advisor at Multiply Labs and is a member of StartX since June 2019. Benedetta was also a member of the S18 Bio Program at Y Combinator before transitioning to a postdoctoral fellowship at Stanford University School of Medicine from May 2015 to June 2018. Academic achievements include a PhD in Molecular Medicine and advanced study in Basic and Applied Immunology at Libera Università Vita-Salute San Raffaele, complemented by a B.S. in Medical and Pharmaceutical Biotechnology. Early career experience includes an internship at Genentech in the Division of Tumor Biology and Angiogenesis.